BetterLife Pharma (BETRF) Retained Earnings (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Retained Earnings of -$88.1 million for Q2 2026, down 5.46% year-over-year from -$93.1 million in Q2 2025, and down 1.75% quarter-over-quarter from -$86.5 million in Q1 2026.
BetterLife Pharma (BETRF) Retained Earnings (2011 - 2026) Analysis & Trends
BetterLife Pharma's Retained Earnings history runs 16 years deep, the most recent figure standing at -$88.1 million for Q2 2026.
- In Q2 2026, Retained Earnings fell 5.46% year-over-year to -$88.1 million; the TTM figure through Apr 2026 stood at -$88.1 million (down 5.46% YoY), while the FY2026 annual figure was -$86.5 million, down 3.58% from the prior year.
- Retained Earnings for Q2 2026 stood at -$88.1 million, down from -$86.5 million in the prior quarter.
- The five-year high for Retained Earnings was $167466.3 in Q1 2024, with the low at -$88.1 million in Q2 2026.
- The 5-year median for Retained Earnings is -$83.9 million (2023), against an average of -$79.7 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 95740.41% in 2022, then jumped 100.2% in 2024.
- BetterLife Pharma's Retained Earnings stood at -$84.0 million in 2022, then increased by 0.1% to -$83.9 million in 2023, then decreased by 2.86% to -$86.3 million in 2024, then decreased by 0.6% to -$86.8 million in 2025, then dropped by 1.41% to -$88.1 million in 2026.
- Business Quant data shows BETRF's Retained Earnings at -$88.1 million in Q2 2026, -$86.5 million in Q1 2026, and -$86.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | -88.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -88.05 Mn |
| Jan 31, 2026 | -86.53 Mn |
| Jul 31, 2025 | -86.83 Mn |
| Apr 30, 2025 | -83.49 Mn |
| Jan 31, 2025 | -83.54 Mn |
| Oct 31, 2024 | -86.31 Mn |
| Jul 31, 2024 | -86.51 Mn |
| Apr 30, 2024 | -86.31 Mn |
| Jan 31, 2024 | 167,466.29 |
| Oct 31, 2023 | -83.91 Mn |
| Jul 31, 2023 | -85.09 Mn |
| Apr 30, 2023 | -83.19 Mn |
| Jan 31, 2023 | -83.17 Mn |
| Oct 31, 2022 | -83.99 Mn |
| Jul 31, 2022 | -83.41 Mn |
| Apr 30, 2022 | -83.82 Mn |
| Jan 31, 2022 | -81.51 Mn |
| Oct 31, 2021 | -78.93 Mn |
| Jul 31, 2021 | -78.98 Mn |
| Apr 30, 2021 | -74.23 Mn |